Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Médecins Sans Frontières backs calls to make Covid vaccines patent-free

Big pharmaceutical firms are hindering efforts to tackle pandemic through monopolies and patents, activists argue

Tim Wyatt
Thursday 19 November 2020 06:29 EST
Comments
Poorer nations fear being cut off from the coming wave of Covid vaccines
Poorer nations fear being cut off from the coming wave of Covid vaccines (Getty Images)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Médecins Sans Frontières (MSF) has warned Western nations they will end up on the “wrong side of history” if they continue to block a campaign to waive patents on coronavirus vaccines and treatments.  

The international medical humanitarian agency has called on wealthy countries, including the UK, to sign-up to a proposal from India and South Africa that would suspend intellectual property rights for Covid drugs and vaccines as long as the pandemic lasts.  

Talks at the World Trade Organisation (WTO) over the plan began last month and have been supported by 99 nations, but many richer countries including the UK, the United States and the EU have so far resisted the proposal.  

MSF said it was vital to relax the normal rules on patents to allow developing nations to produce cheaper, generic versions of lifesaving but patented Covid treatments and bring the pandemic to a close.  

“All Covid-19 health tools and technologies should be true global public goods, free from the barriers that patents and other intellectual property impose,” said Sidney Wong, who is leading MSF’s campaign.  

“We’re calling on all governments to urgently throw their support behind this groundbreaking proposal that puts human lives over corporate profits at this critical moment for global health.

“Governments need to ask themselves which side of history they want to be on when the books on this pandemic are written.”

Poorer nations argue they could cut be cut off from deploying the coming wave of coronavirus vaccines if the huge pharmaceutical corporations producing them are allowed to uphold their patents and sign licensing deals guaranteeing them de facto monopolies. 

A similar waiver to the WTO’s intellectual property rules was agreed in 2001 to tackle the HIV/AIDS crisis, which created more flexibility for the developing world to avoid patent rules that were blocking them from accessing medicines.  

MSF argued drug companies were once again hindering efforts to tackle Covid outside the West so they could generate more profit during the pandemic, by signing restrictive licensing deals which would prevent any generic competition.  

“This bold step by governments offers the world a chance to avoid repeating the tragedy of the HIV/AIDS epidemic 20 years ago, when monopolies on lifesaving treatments saw people in high-income countries get access to HIV medicines while millions in developing countries were left to die,” said Dr Khosi Mavuso, medical representative for MSF in South Africa. 

“Overriding monopolies on Covid-19 medical tools will allow global collaboration to scale-up manufacturing, supply and access for everyone.”

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in